BP11079 PCL, poly(ε-caprolactone), Lauryl Ester Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa

PCL, poly(ε-caprolactone), Lauryl Ester Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Description

PCL, Poly(ε-caprolactone), Lauryl Ester Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa is a biodegradable, semicrystalline aliphatic polyester modified by lauryl ester end-group termination. Its specified intrinsic viscosity and molecular weight range are critical for determining melt flow behaviour, mechanical integrity, and degradation kinetics in biomedical applications. Delivered in powder form, it facilitates uniform dispersion in composite matrices, making it suitable for tissue engineering scaffolds and controlled drug delivery systems.

PCL, poly(ε-caprolactone), Lauryl Ester Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Applications

1.        Healthcare Applications
- Used as a scaffold matrix in tissue engineering to achieve controlled degradation by utilising its biodegradable and biocompatible properties.
- Applied in controlled drug delivery systems to obtain predictable release kinetics by utilising its tailored degradation profile.

2.        Industrial Applications
- Employed as a polymer modifier in additive manufacturing to achieve enhanced flow properties by utilising its controlled molecular weight distribution.

PCL, poly(ε-caprolactone), Lauryl Ester Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Packing

The product is packaged in moisture-resistant, sealed containers that prevent contamination. The powder is enclosed in inert, anti-static packaging to protect it from oxidation and mechanical stress. It is recommended to store the material in cool, dry conditions to preserve its properties. Custom packaging options, including bulk containers and modified atmosphere packaging, are available upon request.

Additional Information

PCL is a biodegradable polyester extensively studied in the field of biocompatible materials. Its controlled degradation and ease of processing make it a valuable material for biomedical applications such as tissue scaffolding and drug delivery systems. Understanding the relationship between molecular weight and intrinsic viscosity is critical for tailoring its performance.

The incorporation of lauryl ester termination modifies the polymer's solubility and compatibility with various matrices, expanding its utility in advanced manufacturing processes. Ongoing research continues to refine processing techniques to optimise performance and reliability across diverse applications.

Regulatory Note: This material is designed for industrial and consumer applications. It is the customer's responsibility to ensure compliance with all applicable safety and regulatory requirements for their intended use.